Αποτελέσματα Αναζήτησης
23 Ιουν 2022 · Treatment and survival. The most common treatment for stage I seminomas is inguinal orchiectomy without chemotherapy or radiation (78%), whereas most patients with stage II disease receive chemotherapy (66%), radiation (19%), or both (<1%) in addition to surgery (Fig. 10).
13 Απρ 2023 · Chimeric antigen receptors (CAR) are engineered fusion proteins designed to target T cells to antigens expressed on cancer cells. CAR T cells are now an established treatment for patients with...
treatment-naive. long-term follow-up. metastatic. overall survival. Key messages. 5-year survival rates in patients with advanced melanoma receiving pembrolizumab in KEYNOTE-001 were 34% overall (73% responses ongoing) and 41% in treatment-naive patients (82% ongoing) 2 of 4 patients receiving second-course pembrolizumab responded.
1 Ιουλ 2023 · The present report succinctly reviews the existing and contemporary advancements in chemotherapy and assesses the status of the enrolled drugs/pharmaceuticals; it also comprehensively discusses the emerging role of specific/targeted therapeutic strategies that are presently being employed to achieve better clinical success/survival rate in ...
3 Μαρ 2008 · Results. Data from 624 trials (781 randomized comparisons) involving 216 451 patients were analyzed. In all, 30% of trials had statistically significant results, of which new interventions were superior to established treatments in 80% of trials.
11 Μαρ 2023 · In the active-monitoring group, 133 men (24.4%) were alive without any prostate cancer treatment at the end of follow-up.
11 Ιουν 2019 · The majority of cancer survivors (68%) were diagnosed 5 or more years ago, and 18% were diagnosed 20 or more years ago (Table 1). Nearly two-thirds (64%) are aged 65 years or older, although age distribution varies by cancer type (Table 2).
